IPSEs IN THE LAST 24H
  • Ursula von der Leyen
    Ursula von der Leyen “I am following the situation in Georgia with great concern and condemn the violence on the streets of Tbilisi. The European Union has also clearly expressed its concerns regarding the law on foreign influence. The Georgian people want a European future for their country.” 17 hours ago
  • Oleksandr Kozachenko
    Oleksandr Kozachenko “If we compare it with the beginning (of the Russian invasion), when we fired up to 100 shells a day, then now, when we fire 30 shells it's a luxury. Sometimes the number of shells fired daily is in single digits.” 17 hours ago
  • Abdallah al-Dardari
    Abdallah al-Dardari “The United Nations Development Programme's initial estimates for the reconstruction of … the Gaza Strip surpasses $30bn and could reach up to $40bn. The scale of the destruction is huge and unprecedented … this is a mission that the global community has not dealt with since World War II.” 17 hours ago
View All IPSEs inserted in the Last 24h

#molnupiravir

Page with all the IPSEs stored in the archive with the tag #molnupiravir linked to them.
The IPSEs are presented in chronological order based on when the IPSEs have been pronounced.

“This decision was made as we prepare to transition into an endemic phase, where we can co-exist with the virus by adding new innovative treatments as 'weapons' to fight COVID-19, apart from vaccinations and other public health measures.”

author
Malaysia's Health Minister
Read More

“Oh, absolutely not. That's such a false narrative that someone says, 'Well now you have a drug.' Remember, the easiest way to stay out of the hospital, and not die, is don't get infected. I mean this idea about 'We have a drug, don't get vaccinated,' just doesn't make any sense.”

author
Top US infectious disease expert
Read More

“The availability of a well-tolerated, effective oral antiviral [molnupiravir] will be particularly useful in supplementing vaccination as a means to reduce the proportion of patients needing hospital care. It is greatly hoped that the antiviral taskforce has, like the vaccines taskforce, preordered courses of this medication so that the UK can, at last, properly manage this condition by treating vaccine breakthrough disease and relieve pressure on the NHS during the forthcoming winter.”

author
Visiting professor in pharmaceutical medicine at King’s College London
Read More

“It exceeded what I thought the drug might be able to do in this clinical trial. When you see a 50% reduction in hospitalisation or death that's a substantial clinical impact.”

author
Vice-president of Merck research molnupiravir
Read More
May
MonTueWedThuFriSatSun
0102030405
06070809101112
13141516171819
20212223242526
2728293031
IPSEs by City
IPSEs by Author
IPSEs by Country
arrow